Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001104659-25-071857
Filing Date
2025-07-29
Accepted
2025-07-29 20:18:49
Documents
1
Period of Report
2025-07-25

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tm2521929-1_4seq1.html 4  
1 OWNERSHIP DOCUMENT tm2521929-1_4seq1.xml 4 17078
  Complete submission text file 0001104659-25-071857.txt   18841
Mailing Address SUITE 200, 1920 YONGE STREET TORONTO A6 M4S 3E2
Business Address SUITE 200, 1920 YONGE STREET TORONTO A6 M4S 3E2 416-847-6898
ProMIS Neurosciences Inc. (Issuer) CIK: 0001374339 (see all company filings)

EIN.: 000000000 | State of Incorp.: Z4 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O JDJFOS, 2 OLIVER STREET SUITE 905 BOSTON MA 02109
Business Address C/O JDJFOS, 2 OLIVER STREET SUITE 905 BOSTON MA 02109 617-686-8672
Title 19 Promis (Reporting) CIK: 0002005531 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 001-41429 | Film No.: 251163621